Search

Search any products, services and so on here.

About 4505 result(s)

Global Mesna (Mesnex) Market Insights, Forecast to 2030

  • Mar 07, 25
  • ID: 1830
  • Pages: 97
  • Figures: 113
  • Views: 15
  • From $4,900

Coenzyme M (commonly known by it's salt form, Mesna) is a synthetic sulfhydryl (thiol) compound. Mesna, sold under the brand name Mesnex among others, is a medication used in those taking cyclophosphamide or ifosfamide to decrease the risk of bleeding from the bladder. It is used either by mouth or injection into a vein. The global Mesna (Mesnex) market is projected to grow from US$ million in 20...


Global Thymosin α1 Market Insights, Forecast to 2030

  • Mar 07, 25
  • ID: 1831
  • Pages: 91
  • Figures: 116
  • Views: 14
  • From $4,900

Thymosins can enhance body immunity and are mainly used in the treatment of hepatitis and tumors. Thymosins mainly include Thymosin, Thymopentin and Thymosin α1. Thymosin α1 is a high-end thymosin. Clinical trials suggest it may be useful in cystic fibrosis, septic shock, acute respiratory distress syndrome, peritonitis, acute cytomegalovirus infection, TB, severe acute respiratory syndrome, and l...


Global Salmon Calcitonin Market Insights, Forecast to 2030

  • Mar 07, 25
  • ID: 1832
  • Pages: 113
  • Figures: 135
  • Views: 12
  • From $4,900

The global Salmon Calcitonin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Salmon Calcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The China market for Salmon Calcit...


Global Gonadorelin Market Insights, Forecast to 2030

  • Mar 07, 25
  • ID: 1833
  • Pages: 92
  • Figures: 114
  • Views: 15
  • From $4,900

Gonadorelin is a gonadotropin-releasing hormone agonist (GnRH agonist) which is used in fertility medicine and to treat amenorrhea and hypogonadism. It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pituitary. The global Gonadorelin market is projected to grow fr...


Global Terlipressin Market Insights, Forecast to 2030

  • Mar 07, 25
  • ID: 1834
  • Pages: 92
  • Figures: 117
  • Views: 14
  • From $4,900

Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help. The global Terlipressin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Terlipressin is estimated...


Global Argireline Market Insights, Forecast to 2030

  • Mar 07, 25
  • ID: 1835
  • Pages: 75
  • Figures: 103
  • Views: 17
  • From $4,900

Argireline is a natural peptide which is a unique, effective anti wrinkle peptide that was proven as first alternative to Botulinum Toxin. The global Argireline market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Argireline is estimated to increase from $ million in 2024 t...


Global Acetyl Hexapeptide-3 (8) Market Insights, Forecast to 2030

  • Mar 07, 25
  • ID: 1836
  • Pages: 74
  • Figures: 106
  • Views: 13
  • From $4,900

Acetyl hexapeptide-3 or acetyl hexapeptide-8 (sources differ) is a synthetic anti-wrinkle cosmetics ingredient. It is a peptide which is a fragment of SNAP-25, a substrate of botulinum toxin (Botox). The global Acetyl Hexapeptide-3 (8) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Can...


Global Atosiban Market Insights, Forecast to 2030

  • Mar 07, 25
  • ID: 1838
  • Pages: 91
  • Figures: 112
  • Views: 11
  • From $4,900

Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labour. The global Atosiban market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Atosiban is estimated to increase...


Global Laryngeal Cancer Therapeutics Market Insights, Forecast to 2030

  • Mar 07, 25
  • ID: 1839
  • Pages: 90
  • Figures: 116
  • Views: 10
  • From $4,900

The global Laryngeal Cancer Therapeutics market is projected to grow from US$ 2200.8 million in 2024 to US$ 3144.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period. The US & Canada market for Laryngeal Cancer Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through...


Global Desmopressin Market Insights, Forecast to 2030

  • Mar 07, 25
  • ID: 1841
  • Pages: 78
  • Figures: 107
  • Views: 9
  • From $4,900

The global Desmopressin market is projected to grow from US$ 1108.5 million in 2024 to US$ 1462.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period. The US & Canada market for Desmopressin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The China market for Desmop...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232